1 May 2015 in The Journal of Pain
1 February 2014 in Clinical Gastroenterology and Hepatology
1 December 2014 in JAMA Surgery
Cervical total disc replacement (CTDR) was developed to treat neck pain and neurologic sequelae associated with cervical disc disease, while preserving motion. The technology is available worldwide and has become increasingly common in the United States since 2007 as several CTDR devices have been approved for use. Several large-scale Food and Drug Administration–regulated Investigational Device Exemption clinical trials consistently demonstrated that CTDR is at least as safe and effective as anterior cervical discectomy and fusion (ACDF) for the treatment of symptoms associated with cervical spondylosis and degenerative disc disease (DDD). However, until now, these trials were limited to the treatment of single-level disease.
1 January 2015 in Annals of Emergency Medicine
1 July 2016 in Neurosurgery
BACKGROUND:. The cervical total disc replacement (cTDR) was developed to treat cervical degenerative disc disease while preserving motion.OBJECTIVE:. Co
1 June 2016 in Journal of the American College of Surgeons
BACKGROUND: The American College of Surgeons Committee on Trauma sets national targets for the accuracy of field trauma triage at ≥95% sensitivity and ≥65% specificity, yet the cost-effectiveness of realizing these goals is unknown. We evaluated the cost-effectiveness of current field trauma triage practices compared with triage strategies consistent with the national targets. STUDY DESIGN: This was a cost-effectiveness analysis using data from 79,937 injured adults transported by 48 emergency medical services agencies to 105 trauma and nontrauma hospitals in 6 regions of the western United States from 2006 through 2008. Incremental differences in survival, quality-adjusted life years (QALYs), costs, and the incremental cost-effectiveness ratio (costs per QALY gained) were estimated for each triage strategy during a 1-year and lifetime horizon using a decision analytic Markov model. We considered an incremental cost-effectiveness ratio threshold of <$100,000 to be cost-effective. RESULTS: For these 6 regions, a high-sensitivity triage strategy consistent with national trauma policy (sensitivity 98.6%, specificity 17.1%) would cost $1,317,333 per QALY gained, and current triage practices (sensitivity 87.2%, specificity 64.0%) cost $88,000 per QALY gained, compared with a moderate sensitivity strategy (sensitivity 71.2%, specificity 66.5%). Refining emergency medical services transport patterns by triage status improved cost-effectiveness. At the trauma-system level, a high-sensitivity triage strategy would save 3.7 additional lives per year at a 1-year cost of $8.78 million, and a moderate sensitivity approach would cost 5.2 additional lives and save $781,616 each year. CONCLUSIONS: A high-sensitivity approach to field triage consistent with national trauma policy is not cost-effective. The most cost-effective approach to field triage appears closely tied to triage specificity and adherence to triage-based emergency medical services transport practices.